Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 11-2009 | 11-2008 | 11-2007 | 12-2006 | 11-2006 | |
| Sales | 867,891 | 1,049,716 | 931,633 | 0 | 983,633 |
| Cost of Goods | 742,615 | 891,139 | 762,582 | N/A | 786,347 |
| Gross Profit | 125,276 | 158,577 | 169,051 | N/A | 197,286 |
| Operating Expenses | 137,977 | 188,860 | 147,422 | 0 | 137,310 |
| Operating Income | -12,086 | -30,144 | 22,211 | N/A | 60,323 |
| Interest Expense | 23 | 114 | 303 | 0 | 611 |
| Other Income | 137 | 1,732 | 4,476 | 0 | 4,940 |
| Pre-tax Income | -11,972 | -28,526 | 26,384 | 0 | 64,652 |
| Income Tax | 4,442 | 19,383 | -1,725 | N/A | 6,474 |
| Net Income Continuous | -16,414 | -47,909 | 28,109 | N/A | 58,178 |
| Net Income | $-16,414 | $-47,909 | $28,109 | $N/A | $58,178 |
| EPS Basic Total Ops | -0.56 | -1.64 | 0.97 | N/A | 2.03 |
| EPS Basic Continuous Ops | -0.56 | -1.64 | 0.97 | N/A | 2.03 |
| EPS Diluted Total Ops | -0.56 | -1.64 | 0.94 | N/A | 1.97 |
| EPS Diluted Continuous Ops | -0.56 | -1.64 | 0.94 | N/A | 1.97 |
| EBITDA(a) | $10,050 | $24,764 | $43,198 | $N/A | $75,551 |